Journey Other Operating Expenses vs Net Income Analysis

DERM Stock

USD 3.69 0.36 10.81%

Journey Medical financial indicator trend analysis is infinitely more than just investigating Journey Medical Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Journey Medical Corp is a good investment. Please check the relationship between Journey Medical Other Operating Expenses and its Net Income accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Other Operating Expenses vs Net Income

Other Operating Expenses vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Journey Medical Corp Other Operating Expenses account and Net Income. At this time, the significance of the direction appears to have pay attention.

The correlation between Journey Medical's Other Operating Expenses and Net Income is -0.95. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income in the same time period over historical financial statements of Journey Medical Corp, assuming nothing else is changed. The correlation between historical values of Journey Medical's Other Operating Expenses and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Journey Medical Corp are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Other Operating Expenses i.e., Journey Medical's Other Operating Expenses and Net Income go up and down completely randomly.

Correlation Coefficient

-0.95

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Journey Medical Corp. It is also known as Journey Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Journey Medical Corp financial statement analysis. It represents the amount of money remaining after all of Journey Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Journey Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Journey Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Journey Medical's Selling General Administrative is very stable compared to the past year. As of the 1st of May 2024, Sales General And Administrative To Revenue is likely to grow to 3.97, while Tax Provision is likely to drop about 102.6 K.

	2021	2022	2023	2024 (projected)
Interest Expense	7.0M	2.0M	1.7M	1.6M
Depreciation And Amortization	2K	60K	3.9M	4.0M

Interest Expense Depreciation And Amortization

Journey Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.78	0.62	0.49	0.48	0.92	-0.18	0.2	-0.83	0.05	0.9	-0.11	0.55	0.99	-0.59	0.31	0.66	0.12	0.8	0.59	0.88	0.78	0.98	0.47	-0.62	0.87
Short Long Term Debt Total	0.78		0.53	0.41	0.29	0.89	-0.05	0.34	-0.82	0.14	0.63	-0.51	0.58	0.84	-0.14	0.19	0.89	0.37	0.69	0.79	0.95	0.68	0.85	0.35	-0.48	0.72
Other Current Liab	0.62	0.53		0.9	-0.16	0.67	-0.24	0.3	-0.6	0.38	0.75	-0.62	-0.07	0.69	-0.17	-0.14	0.74	0.71	0.72	0.47	0.65	0.83	0.72	0.74	0.06	0.2
Total Current Liabilities	0.49	0.41	0.9		-0.23	0.53	-0.24	0.21	-0.46	0.67	0.64	-0.64	-0.2	0.55	0.07	-0.15	0.67	0.75	0.58	0.45	0.54	0.72	0.6	0.79	0.3	0.02
Total Stockholder Equity	0.48	0.29	-0.16	-0.23		0.28	-0.36	-0.6	-0.03	-0.33	0.31	0.49	0.22	0.4	-0.33	0.35	-0.1	-0.54	-0.12	0.12	0.19	-0.17	0.36	0.16	-0.67	0.66
Property Plant And Equipment Net	0.92	0.89	0.67	0.53	0.28		-0.07	0.43	-0.9	0.13	0.74	-0.35	0.53	0.93	-0.36	0.24	0.85	0.39	0.84	0.82	0.96	0.83	0.95	0.46	-0.49	0.76
Current Deferred Revenue	-0.18	-0.05	-0.24	-0.24	-0.36	-0.07		0.34	-0.05	-0.28	-0.16	-0.17	0.23	-0.13	0.11	0.53	0.02	0.05	0.11	-0.18	-0.05	0.01	-0.13	-0.71	-0.24	-0.09
Net Debt	0.2	0.34	0.3	0.21	-0.6	0.43	0.34		-0.68	0.21	0.08	-0.36	0.54	0.23	-0.17	-0.06	0.54	0.44	0.69	0.48	0.5	0.64	0.27	-0.12	0.04	0.15
Retained Earnings	-0.83	-0.82	-0.6	-0.46	-0.03	-0.9	-0.05	-0.68		-0.18	-0.71	0.34	-0.74	-0.85	0.49	-0.15	-0.82	-0.32	-0.95	-0.7	-0.94	-0.91	-0.87	-0.26	0.44	-0.73
Accounts Payable	0.05	0.14	0.38	0.67	-0.33	0.13	-0.28	0.21	-0.18		0.09	-0.39	-0.14	0.06	0.4	-0.19	0.35	0.52	0.17	0.39	0.22	0.3	0.13	0.59	0.6	-0.22
Cash	0.9	0.63	0.75	0.64	0.31	0.74	-0.16	0.08	-0.71	0.09		-0.23	0.32	0.92	-0.57	0.21	0.58	0.17	0.77	0.31	0.73	0.79	0.91	0.51	-0.45	0.66
Non Current Assets Total	-0.11	-0.51	-0.62	-0.64	0.49	-0.35	-0.17	-0.36	0.34	-0.39	-0.23		0.15	-0.26	-0.46	0.22	-0.77	-0.88	-0.38	-0.45	-0.46	-0.48	-0.31	-0.33	-0.28	0.2
Non Currrent Assets Other	0.55	0.58	-0.07	-0.2	0.22	0.53	0.23	0.54	-0.74	-0.14	0.32	0.15		0.52	-0.54	0.35	0.35	-0.28	0.59	0.38	0.62	0.45	0.49	-0.31	-0.66	0.79
Cash And Short Term Investments	0.99	0.84	0.69	0.55	0.4	0.93	-0.13	0.23	-0.85	0.06	0.92	-0.26	0.52		-0.52	0.27	0.74	0.22	0.83	0.6	0.91	0.82	1.0	0.48	-0.59	0.83
Net Receivables	-0.59	-0.14	-0.17	0.07	-0.33	-0.36	0.11	-0.17	0.49	0.4	-0.57	-0.46	-0.54	-0.52		-0.12	0.01	0.42	-0.52	0.04	-0.32	-0.43	-0.47	0.03	0.62	-0.67
Good Will	0.31	0.19	-0.14	-0.15	0.35	0.24	0.53	-0.06	-0.15	-0.19	0.21	0.22	0.35	0.27	-0.12		0.0	-0.23	0.14	-0.02	0.16	0.03	0.25	-0.26	-0.55	0.42
Common Stock Shares Outstanding	0.66	0.89	0.74	0.67	-0.1	0.85	0.02	0.54	-0.82	0.35	0.58	-0.77	0.35	0.74	0.01	0.0		0.72	0.77	0.83	0.91	0.81	0.78	0.47	-0.16	0.42
Short Term Investments	0.12	0.37	0.71	0.75	-0.54	0.39	0.05	0.44	-0.32	0.52	0.17	-0.88	-0.28	0.22	0.42	-0.23	0.72		0.4	0.56	0.41	0.51	0.29	0.52	0.43	-0.27
Non Current Liabilities Total	0.8	0.69	0.72	0.58	-0.12	0.84	0.11	0.69	-0.95	0.17	0.77	-0.38	0.59	0.83	-0.52	0.14	0.77	0.4		0.56	0.87	0.98	0.84	0.29	-0.34	0.61
Other Current Assets	0.59	0.79	0.47	0.45	0.12	0.82	-0.18	0.48	-0.7	0.39	0.31	-0.45	0.38	0.6	0.04	-0.02	0.83	0.56	0.56		0.82	0.58	0.65	0.49	-0.16	0.47
Other Stockholder Equity	0.88	0.95	0.65	0.54	0.19	0.96	-0.05	0.5	-0.94	0.22	0.73	-0.46	0.62	0.91	-0.32	0.16	0.91	0.41	0.87	0.82		0.85	0.93	0.41	-0.46	0.74
Total Liab	0.78	0.68	0.83	0.72	-0.17	0.83	0.01	0.64	-0.91	0.3	0.79	-0.48	0.45	0.82	-0.43	0.03	0.81	0.51	0.98	0.58	0.85		0.84	0.43	-0.2	0.51
Total Current Assets	0.98	0.85	0.72	0.6	0.36	0.95	-0.13	0.27	-0.87	0.13	0.91	-0.31	0.49	1.0	-0.47	0.25	0.78	0.29	0.84	0.65	0.93	0.84		0.51	-0.53	0.8
Short Term Debt	0.47	0.35	0.74	0.79	0.16	0.46	-0.71	-0.12	-0.26	0.59	0.51	-0.33	-0.31	0.48	0.03	-0.26	0.47	0.52	0.29	0.49	0.41	0.43	0.51		0.26	0.11
Intangible Assets	-0.62	-0.48	0.06	0.3	-0.67	-0.49	-0.24	0.04	0.44	0.6	-0.45	-0.28	-0.66	-0.59	0.62	-0.55	-0.16	0.43	-0.34	-0.16	-0.46	-0.2	-0.53	0.26		-0.84
Common Stock	0.87	0.72	0.2	0.02	0.66	0.76	-0.09	0.15	-0.73	-0.22	0.66	0.2	0.79	0.83	-0.67	0.42	0.42	-0.27	0.61	0.47	0.74	0.51	0.8	0.11	-0.84

Click cells to compare fundamentals

Journey Medical Account Relationship Matchups

Journey Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Short Long Term Debt Total	5.3M	5.4M	910K	23.0M	17.7M	16.8M
Other Current Liab	18.8M	4.5M	4.5M	22.2M	20.4M	20.8M
Total Current Liabilities	20.9M	28.1M	51.6M	66.8M	41.9M	46.9M
Total Stockholder Equity	2.8M	10.3M	42.0M	17.0M	20.4M	19.3M
Property Plant And Equipment Net	1.2M	89K	175K	189K	101K	96.0K
Net Debt	502K	(2.8M)	(48.2M)	(9.0M)	(9.7M)	(10.2M)
Retained Earnings	(163K)	5.1M	(38.9M)	(68.5M)	(72.4M)	(76.0M)
Accounts Payable	2.0M	1.8M	22.8M	36.6M	18.3M	15.5M
Cash	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Non Current Assets Total	8.6M	16.7M	12.8M	27.5M	20.4M	16.4M
Non Currrent Assets Other	656K	3.0M	6K	150K	95K	5.7K
Cash And Short Term Investments	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Net Receivables	19.0M	23.9M	23.1M	28.2M	15.2M	17.6M
Liabilities And Stockholders Equity	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Non Current Liabilities Total	10.2M	13.6M	3.6M	21.3M	14.6M	13.9M
Other Current Assets	655K	1.7M	2.4M	3.3M	3.6M	3.2M
Other Stockholder Equity	2.9M	5.2M	80.9M	85.5M	92.7M	88.1M
Total Liab	31.1M	41.6M	55.2M	88.2M	56.5M	93.1M
Total Current Assets	25.3M	35.2M	84.5M	77.7M	56.5M	53.6M
Intangible Assets	7.4M	15.0M	12.6M	27.2M	20.3M	21.3M
Inventory	857K	1.4M	9.9M	14.2M	10.2M	8.2M

Pair Trading with Journey Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Journey Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Journey Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Journey Stock

0.61	HCM	HUTCHMED DRC	Pair Corr
0.56	DRRX	Durect Earnings Call This Week	Pair Corr
0.55	BHC	Bausch Health Companies Financial Report 2nd of May 2024	Pair Corr
0.49	EBS	Emergent Biosolutions Financial Report 14th of May 2024	Pair Corr

The ability to find closely correlated positions to Journey Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Journey Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Journey Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Journey Medical Corp to buy it.

The correlation of Journey Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Journey Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Journey Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Journey Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:

How To Invest In Journey

Details

Is Journey Stock a good investment?

Details

What is Journey Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Journey Stock analysis

When running Journey Medical's price analysis, check to measure Journey Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Journey Medical is operating at the current time. Most of Journey Medical's value examination focuses on studying past and present price action to predict the probability of Journey Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Journey Medical's price. Additionally, you may evaluate how the addition of Journey Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Journey Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.21)

Revenue Per Share

4.343

Quarterly Revenue Growth

(0.04)

Return On Assets

0.0074

Return On Equity

(0.21)

The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Journey Other Operating Expenses vs Net Income Analysis

Other Operating Expenses vs Net Income

Other Operating Expenses vs Net Income Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Net Income

Journey Medical fundamental ratios Correlations

Journey Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Journey Medical fundamental ratios Accounts

Pair Trading with Journey Medical

Moving against Journey Stock

Complementary Tools for Journey Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Non Current Liabilities Total
Other Stockholder Equity	+ 0.96	Property Plant And Equipment Net
Other Stockholder Equity	+ 0.95	Short Long Term Debt Total

Non Current Liabilities Total	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Total Liab	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Short Term Investments	- 0.88	Non Current Assets Total
Total Current Assets	- 0.87	Retained Earnings